E. Cavalcanti

发表

A SARS-CoV-2 Infection High-Uptake Program on Healthcare Workers and Cancer Patients of the National Cancer Institute of Naples, Italy

C. Montagnese, S. Gandini, A. Crispo, 2022, Healthcare.

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance

F. Caponigro, F. Bruzzese, E. Di Gennaro, 2020, Frontiers in Cell and Developmental Biology.

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1

G. Botti, M. Monaco, C. D'Alterio, 2019, Journal of Experimental & Clinical Cancer Research.

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

G. Botti, P. Ascierto, S. Pignata, 2019, PloS one.

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

G. Botti, G. Arpino, S. de Placido, 2017, Oncotarget.

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment

G. Botti, P. Ascierto, G. Ciliberto, 2015, Journal of translational medicine.

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment

G. Botti, P. Ascierto, G. Ciliberto, 2014, Journal of Translational Medicine.

The clinical and translational research activities at the INT – IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic

F. Izzo, P. Delrio, G. Botti, 2020, Infectious agents and cancer.

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

G. Madonna, D. Mallardo, P. Ascierto, 2018, Journal of Immunotherapy for Cancer.

Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

F. Buonaguro, D. Rea, L. Russo, 2021, Infectious agents and cancer.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

G. Botti, G. de Feo, F. Caponigro, 2016, BMC Cancer.

Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

M. Cantile, S. Pignata, M. Di Maio, 2016, Analytical cellular pathology.

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

S. Scala, F. Tatangelo, P. Maiolino, 2015, International journal of surgery.

Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial

G. Pravettoni, L. Nezi, S. Gandini, 2022, BMC cancer.

Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

G. Madonna, P. Ascierto, D. Galati, 2020, Journal of Translational Medicine.

Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection

G. Botti, P. Ascierto, F. Buonaguro, 2020, Journal of translational medicine.

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

A. Avallone, G. Nasti, F. Tatangelo, 2017, Anticancer research.

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol

F. Izzo, P. Delrio, G. Botti, 2020, Therapeutic advances in medical oncology.

24 Nivolumab serum concentration in metastatic melanoma patients could be related to anti-tumor activity gene and outcome

G. Madonna, D. Mallardo, P. Ascierto, 2021, Journal for ImmunoTherapy of Cancer.

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

D. Mallardo, P. Ascierto, E. Simeone, 2022, Journal of Translational Medicine.

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review

F. Caponigro, F. Ionna, P. Maiolino, 2022, Cancers.

Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

C. Montagnese, N. Normanno, F. Buonaguro, 2022, Infectious agents and cancer.

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype

G. D'aiuto, G. Botti, G. Ciliberto, 2014, Diabetology & Metabolic Syndrome.

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring

M. Cantile, C. Sandomenico, A. Morabito, 2021, Journal of circulating biomarkers.

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial

M. Rinaldo, G. Ciliberto, G. Banna, 2017, BMC Cancer.

Ran signaling in melanoma: implications for the development of alternative therapeutic strategies.

F. Marincola, G. Botti, P. Ascierto, 2015, Cancer letters.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

F. Fulciniti, G. Botti, P. Ascierto, 2014, Cancer Immunology, Immunotherapy.

Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications

M. Rinaldo, G. Botti, C. Montagnese, 2020, Nutrients.

Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression

M. Montopoli, M. Berretta, R. Taibi, 2021, Frontiers in Oncology.

Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study

C. la Vecchia, G. Ciliberto, C. Bosetti, 2015, BMC Cancer.

c-Myc modulation: a key role in melanoma drug response

Daniela Alfano, A. Fico, A. Valentino, 2015, Cancer biology & therapy.

Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial

M. Rinaldo, G. Botti, C. Montagnese, 2020, PloS one.

Phenotype characterization of human melanoma cells resistant to dabrafenib

P. Ascierto, G. Ciliberto, A. Cossu, 2017, Oncology reports.

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

F. Fulciniti, G. Botti, P. Ascierto, 2014, Cancer Immunology, Immunotherapy.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19.

M. Berretta, N. Maurea, A. Paccone, 2021, European review for medical and pharmacological sciences.

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience

G. D'aiuto, G. Ciliberto, A. Giordano, 2013, Journal of experimental & clinical cancer research : CR.

Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases

M. Cantile, R. Sabatino, E. Cavalcanti, 2017, International journal of molecular sciences.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

G. Botti, F. Caponigro, S. Scala, 2016, BMC Cancer.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

P. Delrio, G. Botti, E. Di Gennaro, 2014, BMC Cancer.

SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system

N. Normanno, G. Vaccari, F. Bergantino, 2021, Journal of translational medicine.

Implementation of a Hplc Method for the Evaluation of Urinary 4-Hydroxyphenylacetic Acid in Patients with Neuroendocrine Tumors

G. Corso, L. Russo, S. Tafuto, 2020 .

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)

Antonella Petrillo, Vincenza Granata, Gerardo Botti, 2016, BMC Cancer.

Determination of whether screening tests for chronic atrophic gastritis really has a positive predictive value.

G. Botti, M. Cantile, F. Tatangelo, 2015, Molecular medicine reports.

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

D. Mallardo, P. Ascierto, S. Warren, 2022, Journal for immunotherapy of cancer.

HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine

F. Buonaguro, L. Buonaguro, R. Penta, 2021, Frontiers in Immunology.

Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study

C. la Vecchia, G. Ciliberto, C. Bosetti, 2015, BMC Cancer.

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial

G. D'aiuto, G. Botti, G. Ciliberto, 2013, Trials.

Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.

F. Izzo, G. Borgia, M. Piccirillo, 2017, In vivo.

Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

G. Madonna, P. Ascierto, D. Galati, 2020, Journal of Translational Medicine.

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

D. Mallardo, G. Botti, P. Ascierto, 2021, Journal of translational medicine.

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes

M. Rinaldo, G. Botti, G. Botti, 2017, Journal of cellular physiology.

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

D. Mallardo, P. Ascierto, E. Simeone, 2022, Journal of Translational Medicine.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

G. Madonna, D. Mallardo, P. Ascierto, 2023, Journal of Translational Medicine.

Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

F. Buonaguro, D. Rea, L. di Capua, 2021, Infectious Agents and Cancer.

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial

M. Rinaldo, G. Ciliberto, G. Banna, 2017, BMC Cancer.

Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization

M. Tagliamonte, B. Cembrola, E. Cavalcanti, 2024, Frontiers in immunology.

The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives

V. Granata, S. Tafuto, E. Cavalcanti, 2024, Pharmaceuticals.